...
首页> 外文期刊>PLoS One >Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study
【24h】

Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study

机译:血浆 - 细胞肿瘤中的分期,预后,形态,治疗响应和表观扩散系数与背景体信号抑制与背景体信号抑制的相关性:单中心,回顾性研究

获取原文
           

摘要

Accurate staging and evaluation of therapeutic effects are important in managing plasma-cell neoplasms. Diffusion-weighted imaging with body signal suppression magnetic resonance imaging (DWIBS-MRI) allows for acquisition of whole-body volumetric data without radiation exposure. This study aimed to investigate the usefulness of DWIBS-MRI in plasma-cell neoplasms. We retrospectively analyzed 29 and 8 Japanese patients with multiple myeloma and monoclonal gammopathy of undetermined significance, respectively, who underwent DWIBS-MRI. We conducted a histogram analysis of apparent diffusion coefficient values. The correlations between each histogram parameter and staging, cell maturation, prognosis, and treatment response were evaluated. We found that the apparent diffusion coefficient values in patients with monoclonal gammopathy of undetermined significance were lower than those in patients with multiple myeloma. Pretreatment apparent diffusion coefficient values of immature myeloma were lower than those of mature myeloma. Moreover, these values decreased in proportion to stage progression in Durie-Salmon classification system but showed no significant correlation with other staging systems or prognosis. Patients were stratified as responder, stable, and non-responder based on the International Myeloma Working Group criteria. The magnitude of changes in apparent diffusion coefficients differed significantly between responders and non-responders (0.154 ± 0.386 ×10–3 mm2/s vs. -0.307 ± 0.424 ×10–3 mm2/s, p = 0.003). Although its usefulness has yet to be established, DWIBS-MRI combined with apparent diffusion coefficient measurement allowed for excellent response evaluation in patients with multiple myeloma. Furthermore, apparent diffusion coefficient analysis using DWIBS-MRI may be useful in predicting cell maturation and total tumor volume.
机译:治疗效果的准确分期和评估对于管理血浆细胞肿瘤是重要的。具有身体信号抑制磁共振成像(DWIBS-MRI)的扩散加权成像允许在没有辐射曝光的情况下采集全身体积数据。本研究旨在探讨DWIBS-MRI在血浆细胞肿瘤中的有用性。我们回顾性地分析了29例日本日本患者,分别具有多种骨髓瘤和单克隆血管病的患者,分别是突破DWIBS-MRI的显着意义。我们进行了表观扩散系数值的直方图分析。评估每个直方图参数和分段,细胞成熟,预后和治疗响应之间的相关性。我们发现,单克隆血管病患者的明显扩散系数值未定例的显着意义低于多发性骨髓瘤的患者。预处理明显扩散系数值不成熟的骨髓瘤低于成熟骨髓瘤的扩散系数值。此外,这些值与Durie-Salmon分类系统中的阶段进展比例降低,但与其他分期系统或预后无明显相关性。患者基于国际骨髓瘤工作组标准分类为响应者,稳定和非响应者。在响应者和非响应者之间表观扩散系数的变化的大小有显着不同(0.154±0.386×10-3mm2 / s与-0.307±0.424×10-3mm2 / s,p = 0.003)。虽然其有用性尚待建立,但DWIBS-MRI结合表观扩散系数测量,允许多种骨髓瘤患者的优异反应评估。此外,使用DWIBs-MRI的表观扩散系数分析可用于预测细胞成熟和总肿瘤体积。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号